Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Slavin

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
American Journal of Medical Genetics. Part A|April 11, 2014
The perinatal presentation of cardiofaciocutaneous syndromeKara N Wong Ramsey, Matthew H Loichinger, Thomas P Slavin, et al.
Case Reports in Oncology|October 9, 2025
Advanced Minimal Residual Disease Detection Using a Novel Circulating Tumor DNA Assay: A Report of Two CasesGeorges Azzi, Thomas P Slavin, Jesus Izaguirre-Carbonell, et al.
Familial Cancer|September 27, 2019
Novel candidates in early-onset familial colorectal cancerAnne M L Jansen, Pradipta Ghosh, Tikam C Dakal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2020
Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots"Jennifer N Dines, Brian H Shirts, Thomas P Slavin, et al.
NPJ Precision Oncology|November 3, 2024
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testingTuya Pal, Erin Mundt, Marcy E Richardson, et al.
Cancer Genetics|May 7, 2019
Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testingThomas P Slavin, Bradford Coffee, Ryan Bernhisel, et al.
Breast Cancer Research and Treatment|April 21, 2023
The association between age at breast cancer diagnosis and prevalence of pathogenic variantsMary B Daly, Eric Rosenthal, Shelly Cummings, et al.
BMC Cancer|November 3, 2020
Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patientsAva Kwong, Vivian Yvonne Shin, Cecilia Y S Ho, et al.
Journal of Geriatric Oncology|October 3, 2019
Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesisThomas P Slavin, Can-Lan Sun, Yanin Chavarri-Guerra, et al.
Pharmacology & Therapeutics|December 22, 2019
Circulating tumor DNA as an early cancer detection toolAndrea Campos-Carrillo, Jeffrey N Weitzel, Prativa Sahoo, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
American Journal of Medical Genetics. Part A|April 11, 2014
The perinatal presentation of cardiofaciocutaneous syndromeKara N Wong Ramsey, Matthew H Loichinger, Thomas P Slavin, et al.
Case Reports in Oncology|October 9, 2025
Advanced Minimal Residual Disease Detection Using a Novel Circulating Tumor DNA Assay: A Report of Two CasesGeorges Azzi, Thomas P Slavin, Jesus Izaguirre-Carbonell, et al.
Familial Cancer|September 27, 2019
Novel candidates in early-onset familial colorectal cancerAnne M L Jansen, Pradipta Ghosh, Tikam C Dakal, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 9, 2020
Systematic misclassification of missense variants in BRCA1 and BRCA2 "coldspots"Jennifer N Dines, Brian H Shirts, Thomas P Slavin, et al.
NPJ Precision Oncology|November 3, 2024
Reduced penetrance BRCA1 and BRCA2 pathogenic variants in clinical germline genetic testingTuya Pal, Erin Mundt, Marcy E Richardson, et al.
Cancer Genetics|May 7, 2019
Prevalence and characteristics of likely-somatic variants in cancer susceptibility genes among individuals who had hereditary pan-cancer panel testingThomas P Slavin, Bradford Coffee, Ryan Bernhisel, et al.
Breast Cancer Research and Treatment|April 21, 2023
The association between age at breast cancer diagnosis and prevalence of pathogenic variantsMary B Daly, Eric Rosenthal, Shelly Cummings, et al.
BMC Cancer|November 3, 2020
Mutation screening of germline TP53 mutations in high-risk Chinese breast cancer patientsAva Kwong, Vivian Yvonne Shin, Cecilia Y S Ho, et al.
Journal of Geriatric Oncology|October 3, 2019
Older breast cancer survivors may harbor hereditary cancer predisposition pathogenic variants and are at risk for clonal hematopoiesisThomas P Slavin, Can-Lan Sun, Yanin Chavarri-Guerra, et al.
Pharmacology & Therapeutics|December 22, 2019
Circulating tumor DNA as an early cancer detection toolAndrea Campos-Carrillo, Jeffrey N Weitzel, Prativa Sahoo, et al.
Pageof 7